Lista de obras - Mohammad Hojjat-Farsangi

A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib.

artículo científico publicado en 2018

Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer.

artículo científico publicado en 2017

Altered T-cell subpopulations in recurrent pregnancy loss patients with cellular immune abnormalities

artículo científico publicado en 2018

An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein

artículo científico publicado en 2020

Anti-angiogenic effects of CD73-specific siRNA-loaded nanoparticles in breast cancer-bearing mice

artículo científico publicado en 2018

Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis.

artículo científico publicado en 2016

Assessment of the immune system in 55 Iranian patients with vitiligo

scientific article published on 01 November 2005

Association of Tumor Growth Factor-β and Interferon-γ Serum Levels With Insulin Resistance in Normal Pregnancy

artículo científico publicado en 2015

Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells

artículo científico publicado en 2018

Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine

scientific article published on 24 October 2019

CD73 as a potential opportunity for cancer immunotherapy

scientific article published on 26 December 2018

CDK1 in Breast Cancer: Implications for Theranostic Potential

scientific article published on 03 February 2020

Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis

artículo científico publicado en 2012

Concomitant blockade of A2AR and CTLA-4 by siRNA-loaded polyethylene glycol-chitosan-alginate nanoparticles synergistically enhances antitumor T-cell responses

scientific article published on 02 June 2020

Construction and characterization of a new chimeric antibody against HER2.

artículo científico publicado en 2013

Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg).

artículo científico publicado en 2017

Differential regulation of B-cell proliferation by IL21 in different subsets of chronic lymphocytic leukemia.

artículo científico publicado en 2013

Dimethyl fumarate: Regulatory effects on the immune system in the treatment of multiple sclerosis

scientific article published on 07 December 2018

Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia

artículo científico publicado en 2016

Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway

scientific article published on 30 March 2019

E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions

artículo científico publicado en 2019

Expression profile of galectin-1 and galectin-3 molecules in different subtypes of chronic lymphocytic leukemia.

artículo científico publicado en 2010

Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia

artículo científico publicado en 2008

First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells.

artículo científico publicado en 2018

Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy.

artículo científico

Frequency analysis of HLA class I alleles in Iranian patients with progressive and non-progressive chronic lymphocytic leukemia

artículo científico publicado en 2013

Human leukocyte antigen class II allele association to disease progression in Iranian patients with chronic lymphocytic leukemia.

artículo científico publicado en 2008

Ibrutinib-A double-edge sword in cancer and autoimmune disorders.

artículo científico

Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia

artículo científico publicado en 2009

Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.

artículo científico publicado en 2008

Increased frequency of CD8+ and CD4+ regulatory T cells in chronic lymphocytic leukemia: association with disease progression

artículo científico publicado en 2013

Induction of IgM, IgA and IgE antibodies in colorectal cancer patients vaccinated with a recombinant CEA protein

artículo científico publicado en 2012

Lack of Association Between rs17568 Polymorphism in OX40 Gene and Myocardial Infarction, Southern of Iran

artículo científico publicado en 2015

Ligation of human Fc receptor like-2 by monoclonal antibodies down-regulates B-cell receptor-mediated signalling.

artículo científico publicado en 2014

Mechanisms of tumor cell resistance to the current targeted-therapy agents.

artículo científico publicado en 2016

Metabolic syndrome mediates proinflammatory responses of inflammatory cells in preeclampsia

scientific article published on 05 February 2019

Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant Behavior

artículo científico publicado en 2019

Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells.

artículo científico publicado en 2012

Nanoparticles and targeted drug delivery in cancer therapy

artículo científico publicado en 2017

Novel and emerging targeted-based cancer therapy agents and methods

artículo científico publicado en 2015

Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies

artículo científico publicado en 2012

PD-L1/PD-1 axis as a potent therapeutic target in breast cancer

scientific article published on 16 February 2020

Polymorphism of Foxp3 Gene Affects the Frequency of Regulatory T Cells and Disease Activity in Patients with Rheumatoid Arthritis in Iranian Population

article

Promising immunotherapy: Highlighting cytokine-induced killer cells

scientific article published on 16 December 2018

Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer

scientific article published on 15 May 2019

ROR1 Is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells

artículo científico publicado en 2020

Recent advances in targeting mTOR signaling pathway using small molecule inhibitors

artículo científico publicado en 2016

S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy

artículo científico publicado en 2019

Sero-Epidemiological Study of Hepatitis E Virus among Thalassemia as High Risk Patients: A Cross-Sectional Survey in Jahrom, Southern, Iran

artículo científico publicado en 2016

Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression

scientific article published on 28 January 2020

Smac mimetics as novel promising modulators of apoptosis in the treatment of breast cancer

artículo científico publicado en 2018

Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies

artículo científico publicado en 2014

Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia

artículo científico publicado en 2015

T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile.

artículo científico publicado en 2012

Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy

artículo científico

Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances

artículo científico

Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia

artículo científico publicado en 2013

The PI3K/AKT/mTOR pathway is involved in direct apoptosis of CLL cells induced by ROR1 monoclonal antibodies.

artículo científico publicado en 2014

The imbalance of Th17/Treg axis involved in the pathogenesis of preeclampsia

artículo científico publicado en 2018

The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy

artículo científico publicado en 2014

The role of DEAD-box RNA helicase p68 (DDX5) in the development and treatment of breast cancer

artículo científico publicado en 2018

The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer

artículo científico publicado en 2018

The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia.

artículo científico

The tyrosine kinase receptor ROR1 is constitutively phosphorylated in chronic lymphocytic leukemia (CLL) cells.

artículo científico publicado en 2013

Variation in WNT genes expression in different subtypes of chronic lymphocytic leukemia

artículo científico publicado en 2009

Whole Tumor Cell Vaccine Adjuvants: Comparing IL-12 to IL-2 and IL-15.

artículo científico publicado en 2016

Lista de obras de Mohammad Hojjat-Farsangi

A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib.

Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer.

Altered T-cell subpopulations in recurrent pregnancy loss patients with cellular immune abnormalities

An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein

Anti-angiogenic effects of CD73-specific siRNA-loaded nanoparticles in breast cancer-bearing mice

Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis.

Assessment of the immune system in 55 Iranian patients with vitiligo

Association of Tumor Growth Factor-β and Interferon-γ Serum Levels With Insulin Resistance in Normal Pregnancy

Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells

Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine

CD73 as a potential opportunity for cancer immunotherapy

CDK1 in Breast Cancer: Implications for Theranostic Potential

Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis

Concomitant blockade of A2AR and CTLA-4 by siRNA-loaded polyethylene glycol-chitosan-alginate nanoparticles synergistically enhances antitumor T-cell responses

Construction and characterization of a new chimeric antibody against HER2.

Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg).

Differential regulation of B-cell proliferation by IL21 in different subsets of chronic lymphocytic leukemia.

Dimethyl fumarate: Regulatory effects on the immune system in the treatment of multiple sclerosis

Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia

Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway

E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions

Expression profile of galectin-1 and galectin-3 molecules in different subtypes of chronic lymphocytic leukemia.

Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia

First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells.

Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy.

Frequency analysis of HLA class I alleles in Iranian patients with progressive and non-progressive chronic lymphocytic leukemia

Human leukocyte antigen class II allele association to disease progression in Iranian patients with chronic lymphocytic leukemia.

Ibrutinib-A double-edge sword in cancer and autoimmune disorders.

Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia

Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.

Increased frequency of CD8+ and CD4+ regulatory T cells in chronic lymphocytic leukemia: association with disease progression

Induction of IgM, IgA and IgE antibodies in colorectal cancer patients vaccinated with a recombinant CEA protein

Lack of Association Between rs17568 Polymorphism in OX40 Gene and Myocardial Infarction, Southern of Iran

Ligation of human Fc receptor like-2 by monoclonal antibodies down-regulates B-cell receptor-mediated signalling.

Mechanisms of tumor cell resistance to the current targeted-therapy agents.

Metabolic syndrome mediates proinflammatory responses of inflammatory cells in preeclampsia

Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant Behavior

Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells.

Nanoparticles and targeted drug delivery in cancer therapy

Novel and emerging targeted-based cancer therapy agents and methods

Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies

PD-L1/PD-1 axis as a potent therapeutic target in breast cancer

Polymorphism of Foxp3 Gene Affects the Frequency of Regulatory T Cells and Disease Activity in Patients with Rheumatoid Arthritis in Iranian Population

Promising immunotherapy: Highlighting cytokine-induced killer cells

Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer

ROR1 Is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells

Recent advances in targeting mTOR signaling pathway using small molecule inhibitors

S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy

Sero-Epidemiological Study of Hepatitis E Virus among Thalassemia as High Risk Patients: A Cross-Sectional Survey in Jahrom, Southern, Iran

Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression

Smac mimetics as novel promising modulators of apoptosis in the treatment of breast cancer

Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies

Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia

T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile.

Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy

Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances

Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia

The PI3K/AKT/mTOR pathway is involved in direct apoptosis of CLL cells induced by ROR1 monoclonal antibodies.

The imbalance of Th17/Treg axis involved in the pathogenesis of preeclampsia

The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy

The role of DEAD-box RNA helicase p68 (DDX5) in the development and treatment of breast cancer

The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer

The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia.

The tyrosine kinase receptor ROR1 is constitutively phosphorylated in chronic lymphocytic leukemia (CLL) cells.

Variation in WNT genes expression in different subtypes of chronic lymphocytic leukemia

Whole Tumor Cell Vaccine Adjuvants: Comparing IL-12 to IL-2 and IL-15.